1. Home
  2. PVLA vs NC Comparison

PVLA vs NC Comparison

Compare PVLA & NC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PVLA
  • NC
  • Stock Information
  • Founded
  • PVLA 2015
  • NC 1913
  • Country
  • PVLA United States
  • NC United States
  • Employees
  • PVLA N/A
  • NC N/A
  • Industry
  • PVLA Biotechnology: Pharmaceutical Preparations
  • NC Coal Mining
  • Sector
  • PVLA Health Care
  • NC Energy
  • Exchange
  • PVLA Nasdaq
  • NC Nasdaq
  • Market Cap
  • PVLA 308.2M
  • NC 247.6M
  • IPO Year
  • PVLA N/A
  • NC N/A
  • Fundamental
  • Price
  • PVLA $28.00
  • NC $33.78
  • Analyst Decision
  • PVLA Strong Buy
  • NC
  • Analyst Count
  • PVLA 6
  • NC 0
  • Target Price
  • PVLA $43.50
  • NC N/A
  • AVG Volume (30 Days)
  • PVLA 91.8K
  • NC 10.4K
  • Earning Date
  • PVLA 03-31-2025
  • NC 03-05-2025
  • Dividend Yield
  • PVLA N/A
  • NC 2.73%
  • EPS Growth
  • PVLA N/A
  • NC N/A
  • EPS
  • PVLA N/A
  • NC 4.55
  • Revenue
  • PVLA N/A
  • NC $237,708,000.00
  • Revenue This Year
  • PVLA N/A
  • NC N/A
  • Revenue Next Year
  • PVLA N/A
  • NC N/A
  • P/E Ratio
  • PVLA N/A
  • NC $7.43
  • Revenue Growth
  • PVLA N/A
  • NC 10.67
  • 52 Week Low
  • PVLA $6.20
  • NC $25.19
  • 52 Week High
  • PVLA $29.27
  • NC $34.78
  • Technical
  • Relative Strength Index (RSI)
  • PVLA N/A
  • NC 55.57
  • Support Level
  • PVLA N/A
  • NC $33.42
  • Resistance Level
  • PVLA N/A
  • NC $34.67
  • Average True Range (ATR)
  • PVLA 0.00
  • NC 1.07
  • MACD
  • PVLA 0.00
  • NC 0.01
  • Stochastic Oscillator
  • PVLA 0.00
  • NC 60.06

About PVLA Palvella Therapeutics Inc. Common Stock

Palvella Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare genetic skin diseases. It is developing a broad pipeline of product candidates based on its patented QTORIN platform, with an initial focus on serious, rare genetic skin diseases. Palvella's lead product candidate, QTORIN 3.9% rapamycin anhydrous gel, is currently in clinical development for microcystic lymphatic malformations (microcystic LMs) and cutaneous venous malformations.

About NC NACCO Industries Inc.

NACCO Industries Inc is a holding company that operates in the mining and natural resource industries. It has three operating segments that are coal mining, North American mining (NA mining), and minerals management. The majority of its revenue is from the coal mining segment. This segment operates surface coal mines under long-term contracts with power generation companies and an activated carbon producer pursuant to a service-based business model. The NA mining segment provides value-add contract mining and services for producers. Minerals management generates income from royalty-based leases by acquiring and promoting oil, gas, and coal mineral interests. The company is diversifying beyond coal mining due to political and economic pressures associated with carbon emissions.

Share on Social Networks: